Regenerative medicine is steadily redefining the future of cardiovascular care, with cell based therapies moving beyond ...
Cell and gene therapies have demonstrated remarkable clinical potential, but translating scientific breakthroughs into w...
As cell and gene therapies transition from clinical development to commercial reality, the industry's attention is incre...
Antimicrobial resistance (AMR) continues to be recognised as one of the world’s most pressing ...
Polycystic Ovary Syndrome (PCOS) has been renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS), following a 14-y...
New platform leverages the established Curator® platform methodology to industrialize Lentivirus processes from conc...
Cytiva, a Danaher company and a leader in the life sciences industry, and Rockwell Automation, Inc, the world&rsquo...
Novartis has announced that the World Health Organization (WHO) has prequalified Coartem® (artemether-lumefantrine) ...
Merck Launches First Bio-Based Solvent Portfolio for High-Performance Liquid Chromatography Solvents made fro...
Qiagen N.V. has announced its expansion into syndromic testing for bloodstream infections with the launch of the CE-IVDR...
South Korea's Ministry of Health and Welfare recently held a bilateral meeting with Mongolia’s Minister of Health,...
On World TB Day, 24th March, the World Health Organization (WHO) is urging countries to accelerate action to end t...
Alamar Biosciences has announced the launch of the NULISAseq Neuro 220 Panel, its largest precision proteomics panel to ...
The WHO Foundation has announced an expanded collaboration with Novo Nordisk to support global efforts to support health...
Cold storage infrastructure plays a critical role across the life sciences industry, safeguarding vaccin...
As global life sciences companies seek locations that combine skilled talent, scalable infrastructure, a...
In this exclusive conversation with BioSpectrum Asia, Alexander Seyf, CEO and Co founder of Autolomous, ...
Zimbabwe has taken a groundbreaking step in its fight against HIV by launching the administration of lenacapavir, a long...
The European Union is committing €225 million to speed up the development of next-generation flu vaccines that will...
Singleron Biotechnologies has announced the upcoming launch of its GEXSCOPE® FFPE Single Nucleus Transcrip...
Why does TAXIS choose to focus on antimicrobial resistance? What are the key developments taking place at TAXIS to comba...
MS Pharma Group, a leading regional pharmaceutical company in the Middle East and North Africa (MENA) region, has signed...
US-based Nuvation Bio Inc., a global oncology company focused on tackling some of the toughest challenges in cancer trea...
Hong Kong headquartered Insilico Medicine, a leading artificial intelligence (AI)-driven drug discovery company, has ann...
French biopharmaceutical firm Sanofi has entered into an agreement to acquire US-based Dynavax Technologies Corporation,...
